Trade Oscar Health, Inc. - OSCR CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.04 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 13.94 |
Open* | 13.87 |
1-Year Change* | 316.52% |
Day's Range* | 13.64 - 14.2 |
52 wk Range | 2.88-12.12 |
Average Volume (10 days) | 3.94M |
Average Volume (3 months) | 47.08M |
Market Cap | 2.49B |
P/E Ratio | -100.00K |
Shares Outstanding | 226.11M |
Revenue | 5.43B |
EPS | -1.60 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | Feb 7, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 27, 2024 | 14.20 | 0.35 | 2.53% | 13.85 | 14.20 | 13.61 |
Mar 26, 2024 | 13.94 | 0.44 | 3.26% | 13.50 | 14.32 | 13.50 |
Mar 25, 2024 | 13.49 | 0.06 | 0.45% | 13.43 | 13.71 | 13.41 |
Mar 22, 2024 | 13.43 | -0.49 | -3.52% | 13.92 | 14.00 | 13.28 |
Mar 21, 2024 | 13.70 | -0.45 | -3.18% | 14.15 | 14.30 | 13.69 |
Mar 20, 2024 | 14.16 | 0.47 | 3.43% | 13.69 | 14.24 | 13.43 |
Mar 19, 2024 | 13.79 | 0.12 | 0.88% | 13.67 | 13.90 | 13.50 |
Mar 18, 2024 | 13.81 | 0.01 | 0.07% | 13.80 | 14.06 | 13.69 |
Mar 15, 2024 | 13.84 | 0.02 | 0.14% | 13.82 | 14.13 | 13.70 |
Mar 14, 2024 | 13.92 | -0.17 | -1.21% | 14.09 | 14.45 | 13.62 |
Mar 13, 2024 | 14.21 | -0.26 | -1.80% | 14.47 | 15.39 | 14.09 |
Mar 12, 2024 | 14.57 | -0.01 | -0.07% | 14.58 | 14.73 | 14.24 |
Mar 11, 2024 | 14.53 | 0.08 | 0.55% | 14.45 | 14.80 | 14.32 |
Mar 8, 2024 | 14.61 | 0.31 | 2.17% | 14.30 | 14.98 | 14.06 |
Mar 7, 2024 | 14.30 | -0.56 | -3.77% | 14.86 | 14.98 | 14.06 |
Mar 6, 2024 | 14.93 | 0.83 | 5.89% | 14.10 | 15.18 | 13.94 |
Mar 5, 2024 | 13.89 | -0.76 | -5.19% | 14.65 | 14.90 | 13.82 |
Mar 4, 2024 | 15.31 | -1.37 | -8.21% | 16.68 | 17.20 | 15.23 |
Mar 1, 2024 | 16.55 | 0.25 | 1.53% | 16.30 | 16.79 | 16.15 |
Feb 29, 2024 | 16.24 | 0.12 | 0.74% | 16.12 | 16.56 | 15.91 |
Oscar Health, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, May 7, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q1 2024 Oscar Health Inc Earnings Release Q1 2024 Oscar Health Inc Earnings ReleaseForecast -Previous - |
Friday, June 7, 2024 | ||
Time (UTC) 14:00 | Country US
| Event Oscar Health Inc Annual Shareholders Meeting Oscar Health Inc Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total revenue | 3963.64 | 1838.71 | 462.801 | 488.188 |
Total Operating Expense | 4553.5 | 2403.37 | 865.067 | 747.577 |
Selling/General/Admin. Expenses, Total | 627.513 | 431.853 | 274.378 | 169.568 |
Depreciation / Amortization | 15.283 | 14.605 | 11.285 | 6.899 |
Operating Income | -589.867 | -564.659 | -402.266 | -259.389 |
Interest Income (Expense), Net Non-Operating | -22.623 | -4.72 | -3.514 | 0 |
Net Income Before Taxes | -610.075 | -570.58 | -405.78 | -259.389 |
Net Income After Taxes | -609.552 | -571.426 | -406.825 | -261.182 |
Net Income Before Extra. Items | -606.275 | -572.606 | -406.825 | -261.182 |
Net Income | -606.275 | -572.606 | -406.825 | -261.182 |
Income Available to Common Excl. Extra. Items | -606.275 | -572.606 | -406.825 | -261.182 |
Income Available to Common Incl. Extra. Items | -606.275 | -572.606 | -406.825 | -261.182 |
Diluted Net Income | -606.275 | -572.606 | -406.825 | -261.182 |
Diluted Weighted Average Shares | 212.475 | 178.967 | 197.037 | 197.037 |
Diluted EPS Excluding Extraordinary Items | -2.8534 | -3.19951 | -2.06471 | -1.32554 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
Diluted Normalized EPS | -2.8534 | -3.12295 | -2.23769 | -1.33856 |
Total Premiums Earned | 3871.12 | 1831.02 | 455.035 | 468.861 |
Net Investment Income | 93.795 | 7.483 | 6.527 | 18.846 |
Realized Gains (Losses) | -1.274 | 0.212 | 1.239 | 0.481 |
Losses, Benefits, and Adjustments, Total | 3910.71 | 1936.74 | 579.404 | 571.11 |
Unusual Expense (Income) | 0 | 20.178 | ||
Other, Net | 2.415 | -1.201 | ||
Minority Interest | 3.277 | -1.18 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 1521.54 | 1469.69 | 995.127 | 978.427 | 1017.32 |
Total Operating Expense | 1528.06 | 1495.05 | 1217.61 | 1170.8 | 1123.81 |
Selling/General/Admin. Expenses, Total | 149.1 | 176.041 | 147.596 | 149.671 | 149.503 |
Unusual Expense (Income) | 0 | 0 | 0 | ||
Operating Income | -6.529 | -25.365 | -222.479 | -192.372 | -106.487 |
Interest Income (Expense), Net Non-Operating | -6.12 | -6.136 | -6.135 | -6.126 | -6.141 |
Other, Net | -1.612 | -6.106 | 1.339 | 3.336 | 0.793 |
Net Income Before Taxes | -14.261 | -37.607 | -227.275 | -195.162 | -111.835 |
Net Income After Taxes | -15.425 | -39.628 | -226.56 | -193.547 | -112.125 |
Minority Interest | -0.103 | -0.144 | 0.514 | 0.634 | -0.039 |
Net Income Before Extra. Items | -15.528 | -39.772 | -226.046 | -192.913 | -112.164 |
Net Income | -15.528 | -39.772 | -226.046 | -192.913 | -112.164 |
Income Available to Common Excl. Extra. Items | -15.528 | -39.772 | -226.046 | -192.913 | -112.164 |
Income Available to Common Incl. Extra. Items | -15.528 | -39.772 | -226.046 | -192.913 | -112.164 |
Diluted Net Income | -15.528 | -39.772 | -226.046 | -192.913 | -112.164 |
Diluted Weighted Average Shares | 219.4 | 216.913 | 215.217 | 212.823 | 211.311 |
Diluted EPS Excluding Extraordinary Items | -0.07077 | -0.18335 | -1.05031 | -0.90645 | -0.5308 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.07077 | -0.18335 | -1.05031 | -0.90645 | -0.5308 |
Total Premiums Earned | 1474.97 | 1428.63 | 967.457 | 953.664 | 994.595 |
Net Investment Income | 46.535 | 41.102 | 27.674 | 25.524 | 22.652 |
Realized Gains (Losses) | 0.034 | -0.043 | -0.004 | -0.761 | 0.072 |
Losses, Benefits, and Adjustments, Total | 1378.96 | 1319.01 | 1070.01 | 1021.13 | 974.303 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Cash & Equivalents | 1558.59 | 1103.99 | 826.326 | 336.644 |
Total Receivables, Net | 49.861 | 40.659 | 31.157 | 25.122 |
Total Assets | 4526.6 | 3321.65 | 2272.11 | 1346.91 |
Property/Plant/Equipment, Total - Net | 127.889 | 119.571 | 35.812 | 33.076 |
Property/Plant/Equipment, Total - Gross | 117.272 | 88.712 | 63.308 | 49.286 |
Accumulated Depreciation, Total | -57.384 | -42.101 | -27.496 | -16.21 |
Long Term Investments | 1620.21 | 1431.56 | 692.127 | 363.228 |
Other Long Term Assets, Total | 27.483 | 28.68 | 26.971 | 25.505 |
Other Assets, Total | 926.092 | 458.769 | 594.391 | 533.271 |
Accounts Payable | 285.017 | 219.957 | 137.524 | 61.724 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 |
Total Liabilities | 3636.22 | 1934.42 | 1823.09 | 996.308 |
Total Long Term Debt | 297.999 | 0 | 142.487 | 0 |
Long Term Debt | 297.999 | 0 | 142.487 | 0 |
Other Liabilities, Total | 0.105 | 0 | 15.005 | 8.819 |
Total Equity | 890.384 | 1387.23 | 449.018 | 350.606 |
Redeemable Preferred Stock | 0 | 0 | 1744.91 | 1295.74 |
Common Stock | 0.002 | 0.002 | 0.002 | 0.002 |
Additional Paid-In Capital | 3509.01 | 3393.53 | 133.255 | 70.673 |
Retained Earnings (Accumulated Deficit) | -2605.99 | -1999.71 | -1427.11 | -1012.86 |
Treasury Stock - Common | -2.923 | -2.923 | -2.923 | -2.923 |
Unrealized Gain (Loss) | -9.715 | -3.671 | 0.879 | -0.027 |
Total Liabilities & Shareholders’ Equity | 4526.6 | 3321.65 | 2272.11 | 1346.91 |
Total Common Shares Outstanding | 215.977 | 210.013 | 197.037 | 197.037 |
Accrued Expenses | 84.999 | 91.67 | ||
Minority Interest | 2.016 | 5.293 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Cash & Equivalents | 1399.79 | 2322.07 | 2109.57 | 1558.59 | 2112.93 |
Total Receivables, Net | 54.127 | 60.335 | 48.122 | 49.861 | 44.256 |
Total Assets | 3349.51 | 4564.94 | 4483.03 | 4526.6 | 4308.71 |
Property/Plant/Equipment, Total - Net | 62.022 | 63.053 | 64.083 | 59.888 | 56.492 |
Long Term Investments | 1224.08 | 1445.34 | 1489.78 | 1620.21 | 914.682 |
Other Long Term Assets, Total | 27.335 | 27.292 | 27.287 | 27.483 | 27.459 |
Other Assets, Total | 375.06 | 453.774 | 558.149 | 994.093 | 937.419 |
Accounts Payable | 260.137 | 261.519 | 299.461 | 285.017 | 252.358 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2430.03 | 3615.24 | 3553.43 | 3636.22 | 3226.67 |
Total Long Term Debt | 298.583 | 298.388 | 298.194 | 297.999 | 297.805 |
Long Term Debt | 298.583 | 298.388 | 298.194 | 297.999 | 297.805 |
Other Liabilities, Total | 68.618 | 70.275 | 71.376 | 0.105 | 73.791 |
Total Equity | 919.476 | 949.702 | 929.602 | 890.384 | 1082.04 |
Common Stock | 0.00235 | 0.002 | 0.002 | 0.002 | 0.002 |
Additional Paid-In Capital | 3653.53 | 3620.77 | 3582.76 | 3509.01 | 3479.39 |
Retained Earnings (Accumulated Deficit) | -2726.69 | -2661.29 | -2645.76 | -2605.99 | -2379.94 |
Treasury Stock - Common | -2.923 | -2.923 | -2.923 | -2.923 | -2.923 |
Unrealized Gain (Loss) | -4.453 | -6.856 | -4.479 | -9.715 | -14.491 |
Total Liabilities & Shareholders’ Equity | 3349.51 | 4564.94 | 4483.03 | 4526.6 | 4308.71 |
Total Common Shares Outstanding | 225.778 | 221.591 | 218.035 | 215.977 | 214.441 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 84.999 | ||||
Minority Interest | 1.958 | 2.263 | 2.16 | 2.016 | 2.53 |
Other Equity, Total | -0.00035 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Net income/Starting Line | -609.552 | -571.426 | -406.825 | -261.182 |
Cash From Operating Activities | 380.349 | -181.745 | 222.732 | -165.37 |
Cash From Operating Activities | 15.283 | 14.605 | 11.285 | 6.899 |
Deferred Taxes | -0.165 | -0.101 | -0.067 | -0.426 |
Non-Cash Items | 115.522 | 127.69 | 43.885 | 27.613 |
Changes in Working Capital | 859.261 | 247.487 | 574.454 | 61.726 |
Cash From Investing Activities | -226.519 | -774.515 | -344.714 | 150.513 |
Capital Expenditures | -29.012 | -25.885 | -14.021 | -25.996 |
Other Investing Cash Flow Items, Total | -197.507 | -748.63 | -330.693 | 176.509 |
Cash From Financing Activities | 301.11 | 1238.71 | 611.707 | -2.119 |
Financing Cash Flow Items | -5.189 | -15.211 | -4.84 | 0 |
Issuance (Retirement) of Stock, Net | 1.299 | 1407.1 | 469.547 | -2.119 |
Issuance (Retirement) of Debt, Net | 305 | -153.173 | 147 | 0 |
Net Change in Cash | 454.94 | 282.452 | 489.725 | -16.976 |
Cash Taxes Paid | 1.893 | 0.697 | ||
Cash Interest Paid | 10.079 | 4.256 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -39.628 | -609.552 | -382.992 | -189.445 | -77.32 |
Cash From Operating Activities | 414.715 | 380.349 | 228.955 | 777.316 | 562.849 |
Cash From Operating Activities | 4.939 | 15.283 | 11.548 | 7.49 | 3.799 |
Deferred Taxes | -0.183 | -0.165 | 0.006 | 0.004 | 0 |
Non-Cash Items | 64.366 | 115.522 | 87.898 | 58.146 | 29.741 |
Cash Interest Paid | 11.319 | 10.079 | 9.81 | 9.55 | 0.261 |
Changes in Working Capital | 385.221 | 859.261 | 512.495 | 901.121 | 606.629 |
Cash From Investing Activities | 135.509 | -226.519 | 480.161 | 181.388 | 102.811 |
Capital Expenditures | -7.379 | -29.012 | -21.882 | -12.265 | -6.247 |
Other Investing Cash Flow Items, Total | 142.888 | -197.507 | 502.043 | 193.653 | 109.058 |
Cash From Financing Activities | 0.506 | 301.11 | 300.583 | 300.16 | 298.775 |
Financing Cash Flow Items | 0.471 | -5.189 | -5.711 | -5.764 | -6.785 |
Issuance (Retirement) of Stock, Net | 0.035 | 1.299 | 1.294 | 0.924 | 0.56 |
Issuance (Retirement) of Debt, Net | 0 | 305 | 305 | 305 | 305 |
Net Change in Cash | 550.73 | 454.94 | 1009.7 | 1258.86 | 964.435 |
Cash Taxes Paid | 1.893 | 1.66 | 1.105 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Oscar Health, Inc. Company profile
Check out our live chart to get all the information you need on the Oscar Health stock price today
Oscar Health (OSCR) is a technology-led health insurance provider based in the US. The company combines its technology platform with a personalised, consumer-focused approach to healthcare services.
Oscar Health’s mobile app and website allow users to sign up for and manage their health insurance, doctor appointments, prescriptions and other care options online, and a dedicated care team provides tailored guidance. The firm sells health insurance plans with tiered premiums, allowing customers to select the plan that most suits their needs.
Oscar Health Insurance Co. (OSCR) stock was listed publicly in March 2021, with the company’s shares now trading on the New York Stock Exchange (NYSE).
Join Capital.com today to stay up to date with the company’s latest news and follow the Oscar Health share price quote live.
One of the companies leading the charge in rolling out telemedicine services in the US, Oscar Health was founded in 2012 by Joshua Kushner (the brother of Jared Kushner, former US president Donald Trump’s son-in-law), Mario Schlosser and Kevin Nazemi, who is no longer with the business. The firm changed its name from Mulberry Health in January 2021.
Since 2017, the company has grown from 15,000 members in one state to 529,000 members in 18 states, and it plans to expand into new areas to tap into the growing US healthcare industry.
The healthcare landscape in the US is complex and undergoing a transition to incorporate digital experiences and customer engagement. Although there are opportunities for growth as healthcare spending continues to increase, the industry is highly competitive. Oscar Health made a loss of $406.8m in 2020, up from $259.4m in 2019, while its revenues fell to $462.8m from $488.2m.
With Capital.com’s comprehensive OSCR stock chart, you can view the company’s current share price and track the performance of the stock since its listing.
Oscar Health held its initial public offering (IPO) on March 3, 2021. Ahead of the listing, the company increased the number of shares on offer as well as their price, reflecting strong interest among investors in telemedicine IPOs. In the offering, the business sold 37 million shares at $39 each, raising nearly $1.44bn. The stock started trading at $36 per share and closed its first day on the NYSE at $34.80 per share.
Are you looking to trade the stock right now? You can go long or short on the company’s shares and trace all the latest ups and downs of the Oscar Health (OSCR) share price using Capital.com’s proprietary CFD trading platform.
Industry: | Health Insurance |
75 Varick Street
5th Floor
NEW YORK
NEW YORK 10013
US
Income Statement
- Annual
- Quarterly
News
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com